Credit: Technology Networks.

Armon Sharei, PhD profile page

CEO and Founder

Dr. Sharei obtained a PhD in chemical engineering MIT and completed his postdoctoral work in immunology at Harvard Medical School. He is the founder and former CEO of SQZ Biotechnologies, having led the company from invention to post-IPO with over $300M in equity financing and a $1 billion Roche collaboration. Dr. Sharei has also led the implementation of three oncology clinical trials.

Accreditations

Doctor of Philosophy recognised by Massachusetts Institute of Technology

Got a Question for Armon Sharei, PhD?

Get in touch using the contact form linked here and we'll get back to you shortly.

Published Content

Total: 1

Cute illustration of cell division with smiling cartoon cells, representing cell engineering.

Industry Insight

Presenting a Universal Cell Engineering Solution

Portal Bio’s microfluidic technology enhances drug discovery and cell engineering by enabling efficient, scalable molecular delivery for sensitive cell types.